Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study.

Nickler M, Ottiger M, Steuer C, Kutz A, Christ-Crain M, Zimmerli W, Thomann R, Hoess C, Henzen C, Bernasconi L, Huber A, Mueller B, Schuetz P; ProHOSP Study Group..

Crit Care. 2017 Mar 24;21(1):72. doi: 10.1186/s13054-017-1656-7.

PMID:
28335807
2.

The National Early Warning Score (NEWS) for outcome prediction in emergency department patients with community-acquired pneumonia: results from a 6-year prospective cohort study.

Sbiti-Rohr D, Kutz A, Christ-Crain M, Thomann R, Zimmerli W, Hoess C, Henzen C, Mueller B, Schuetz P; ProHOSP Study Group..

BMJ Open. 2016 Sep 28;6(9):e011021. doi: 10.1136/bmjopen-2015-011021.

3.

Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients.

Kutz A, Grolimund E, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Zimmerli W, Mueller B, Schuetz P; ProHOSP Study Group..

BMC Anesthesiol. 2014 Nov 15;14:102. doi: 10.1186/1471-2253-14-102.

4.

Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type.

Grolimund E, Kutz A, Marlowe RJ, Vögeli A, Alan M, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Zimmerli W, Mueller B, Schuetz P; ProHOSP Study Group..

COPD. 2015 Jun;12(3):295-305. doi: 10.3109/15412555.2014.949002.

PMID:
25230352
5.

Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.

Zhydkov A, Christ-Crain M, Thomann R, Hoess C, Henzen C, Werner Z, Mueller B, Schuetz P; ProHOSP Study Group..

Clin Chem Lab Med. 2015 Mar;53(4):559-66.

PMID:
25014522
6.

Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.

Schuetz P, Kutz A, Grolimund E, Haubitz S, Demann D, Vögeli A, Hitz F, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Marlowe RJ, Zimmerli W, Mueller B; ProHOSP Study Group..

Int J Cardiol. 2014 Aug 20;175(3):464-72. doi: 10.1016/j.ijcard.2014.06.022.

PMID:
25005339
7.

Hyponatremia and anti-diuretic hormone in Legionnaires' disease.

Schuetz P, Haubitz S, Christ-Crain M, Albrich WC, Zimmerli W, Mueller B; ProHOSP Study Group..

BMC Infect Dis. 2013 Dec 11;13:585. doi: 10.1186/1471-2334-13-585.

8.

The use of copeptin, the stable peptide of the vasopressin precursor, in the differential diagnosis of sodium imbalance in patients with acute diseases.

Nigro N, Müller B, Morgenthaler N, Fluri F, Schütz P, Neidert S, Stolz D, Bingisser R, Tamm M, Christ-Crain M, Katan M.

Swiss Med Wkly. 2011 Oct 11;141:w13270. doi: 10.4414/smw.2011.13270.

9.

Anterior pituitary axis hormones and outcome in acute ischaemic stroke.

Neidert S, Katan M, Schuetz P, Fluri F, Ernst A, Bingisser R, Kappos L, Engelter ST, Steck A, Müller B, Christ-Crain M.

J Intern Med. 2011 Apr;269(4):420-32. doi: 10.1111/j.1365-2796.2010.02327.x.

10.

Guidance of antibiotic therapy with procalcitonin in lower respiratory tract infections: insights into the ProHOSP study.

Schuetz P, Christ-Crain M, Albrich W, Zimmerli W, Mueller B; ProHOSP Study Group..

Virulence. 2010 Mar-Apr;1(2):88-92. doi: 10.4161/viru.1.2.10488.

PMID:
21178422
11.

Prognostic value of procalcitonin in community-acquired pneumonia.

Schuetz P, Suter-Widmer I, Chaudri A, Christ-Crain M, Zimmerli W, Mueller B; Procalcitonin-Guided Antibiotic Therapy and Hospitalisation in Patients with Lower Respiratory Tract Infections (ProHOSP) Study Group..

Eur Respir J. 2011 Feb;37(2):384-92. doi: 10.1183/09031936.00035610.

12.

Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections.

Schuetz P, Wolbers M, Christ-Crain M, Thomann R, Falconnier C, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Morgenthaler NG, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B; ProHOSP Study Group..

Crit Care. 2010;14(3):R106. doi: 10.1186/cc9055.

13.

Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial.

Müller F, Christ-Crain M, Bregenzer T, Krause M, Zimmerli W, Mueller B, Schuetz P; ProHOSP Study Group..

Chest. 2010 Jul;138(1):121-9. doi: 10.1378/chest.09-2920.

PMID:
20299634
14.

Which patients with lower respiratory tract infections need inpatient treatment? Perceptions of physicians, nurses, patients and relatives.

Baehni C, Meier S, Spreiter P, Schild U, Regez K, Bossart R, Thomann R, Falconnier C, Christ-Crain M, De Geest S, Müller B, Schuetz P; ProHOSP Study Group..

BMC Pulm Med. 2010 Mar 11;10:12. doi: 10.1186/1471-2466-10-12.

15.

Dexamethasone suppression test predicts later development of an impaired adrenal function after a 14-day course of prednisone in healthy volunteers.

Neidert S, Schuetz P, Mueller B, Christ-Crain M.

Eur J Endocrinol. 2010 May;162(5):943-9. doi: 10.1530/EJE-09-0930.

16.

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B; ProHOSP Study Group..

JAMA. 2009 Sep 9;302(10):1059-66. doi: 10.1001/jama.2009.1297.

PMID:
19738090
17.

Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.

Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C, Widmer I, Neidert S, Blum CA, Schönenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Müller B; ProHOSP study group..

BMC Health Serv Res. 2007 Jul 5;7:102.

18.

Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus.

Jöhren O, Neidert SJ, Kummer M, Dominiak P.

Peptides. 2002 Jun;23(6):1177-80.

PMID:
12126748
19.

Prepro-Orexin and Orexin Receptor mRNAs Are Differentially Expressed in Peripheral Tissues of Male and Female Rats.

Jo Hren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P.

Endocrinology. 2001 Aug 1;142(8):3324-3331. doi: 10.1210/endo.142.8.8299. No abstract available.

PMID:
28201378
20.

Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats.

Jöhren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P.

Endocrinology. 2001 Aug;142(8):3324-31.

PMID:
11459774

Supplemental Content

Loading ...
Support Center